Comparative Efficacy of Ivermectin and Levamisole for Reduction of Migrating and Encapsulated Larvae of Baylisascaris transfuga in Mice
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The comparative efficacy of 2 anthelmintics (ivermectin and levamisole) against Baylisascaris transfuga migrating and encapsulated larvae was studied in mice. A total of 60 BALB/c mice inoculated each with about 1,000 embryonated B. transfuga eggs were equally divided into 6 groups (A-F) randomly. Mice of groups A and B were treated with ivermectin and levamisole, respectively, on day 3 post-infection (PI). Mice of groups A-C were killed on day 13 PI. Similarly, groups D and E were treated with ivermectin and levamisole, respectively, on day 14 PI, and all mice of groups D-F were treated on day 24 PI. The groups C and F were controls. Microexamination was conducted to count the larvae recovering from each mouse. The percentages of reduction in the number of migrating larvae recovered from group A (ivermectin) and B (levamisole) were 88.3% and 81.1%, respectively. In addition, the reduction in encapsulated larvae counts achieved by ivermectin (group D) and levamisole (group E) was 75.0% and 49.2%, respectively. The results suggested that, to a certain extent, both anthelmintics appeared to be more effective against migrating larvae than encapsulated larvae. However, in the incipient stage of infection, ivermectin may be more competent than levamisole as a larvicidal drug for B. transfuga.
Abstract
The comparative efficacy of 2 anthelmintics (ivermectin and levamisole) against Baylisascaris transfuga migrating and encapsulated larvae was studied in mice. A total of 60 BALB/c mice inoculated each with about 1,000 embryonated B. transfuga eggs were equally divided into 6 groups (A-F) randomly. Mice of groups A and B were treated with ivermectin and levamisole, respectively, on day 3 post-infection (PI). Mice of groups A-C were killed on day 13 PI. Similarly, groups D and E were treated with ivermectin and levamisole, respectively, on day 14 PI, and all mice of groups D-F were treated on day 24 PI. The groups C and F were controls. Microexamination was conducted to count the larvae recovering from each mouse. The percentages of reduction in the number of migrating larvae recovered from group A (ivermectin) and B (levamisole) were 88.3% and 81.1%, respectively. In addition, the reduction in encapsulated larvae counts achieved by ivermectin (group D) and levamisole (group E) was 75.0% and 49.2%, respectively. The results suggested that, to a certain extent, both anthelmintics appeared to be more effective against migrating larvae than encapsulated larvae. However, in the incipient stage of infection, ivermectin may be more competent than levamisole as a larvicidal drug for B. transfuga.
참고문헌 (22)
- Papini R, "A report on the pathology of Baylisascaris transfuga (Ascarididae: Nematoda) for mice", Rev Med Vet, 145, pp.949~952 (1994)
- Sprent JF, "Observations relating to the diagnosis of visceral larval migrans", In Corradetti A ed, Proc First Int Congr Parasitol, 2, pp.802~803 (1964)
- Papini R, "Parenteral infection in mice with Baylisascaris transfuga (Nematoda: Ascaridae) infective eggs", Folia Parasitol, 42, pp.69~71 (1995)
- Kazacos KR, "Baylisascaris procyonis and related species. In Samuel WM, Kocan AA, Pybus MJ ed, Parasitic Diseases of Wild Mammals. 2nd ed", pp.301~364 (2001), Ames, Iowa, USA. Iowa State University
- Papini R, "Experimental infection in chickens with larvae of Baylisascaris transfuga (Nematoda: Ascaridae)", Folia Parasitol, 40, pp.141~143 (1993)
- Bauer C, "Efficacy of six anthelmintics against luminal stages of Baylisascaris procyonis in naturally infected raccoons (Procyon lator)", Vet Parasitol, 60, pp.155~159 (1995)
- Wise ME, "Severe and fatal central nervous system disease in humans caused by Baylisascaris procyonis, the common roundworm of raccoons: a review of current literature", Microbes Infect, 7, pp.317~323 (2005)
- Papini R, "Effect of ivermectin on the migration of Baylisascaris transfuga larvae into the brain of mice", Folia Parasitol, 43, pp.157~158 (1996)
- Ottesen EA, "The role of albendazole in programmes to eliminate lymphatic filariasis", Parasitol Today, 15, pp.382~386 (1999)
- Feng XP, "Study of the nematode putative GABA type-A receptor subunits: evidence for modulation by ivermectin", J Neurochem, 83, pp.870~878 (2002)
- Cho S, "Migration behaviour and pathogenesis of five ascarid nematode species in the Mongolian gerbil Meriones unguiculatus", J Helminthol, 81, pp.43~47 (2007)
- González Canga A, "The pharmacokinetics and metabolism of ivermectin in domestic animal species", Vet J, 179, pp.25~37 (2009)
- Campbell WC, "Ivermectin: a review of efficacy and safety", J Vet Pharmacol Ther, 7, pp.1~16 (1984)
- Shoop WL, "Mutual resistance to avermectins and milbermycins: oral activity of ivermectin and moxidectin against ivermectin-resistance and susceptible nema todes", Vet Rec, 133, pp.445~447 (1993)
- Goldstein G, "Mode of action of levamisole", J Rheumatol Suppl, 4, pp.143~148 (1978)
- Bennett DG, "Clinical pharmacology of ivermectin", J Am Vet Med Assoc, 189, pp.100~104 (1986)
- Lin LC, "Pharmacokinetics and brain distribution of unbound levamisole in the anesthetized rats using microdialysis and microbore column liquid chromatography", Anal Chim Acta, 569, pp.145~150 (2006)
- Hirata M, "Cytokine regulation in experimentally-induced Schistosoma japonicum egg granuloma formation", Parasitol Int, 52, pp.341~349 (2003)
- Co DO, "T cell contributions to the different phases of granuloma formation", Immunol Lett, 92, pp.135~142 (2004)
- Sprent JF, "On the migratory behavior of the larvae of various Ascaris species in white mice: I. Distribution of larvae in tissues", J Infect Dis, 90, pp.165~176 (1952)
- Sugane K, "Interrelationship of eosinophilia and IgE antibody production to larval ES antigen in Toxocara canis infected mice", Parasite Immunol, 6, pp.409~420 (1984)
- Papini R, "Observations on the infectivity of Baylisascaris transfuga eggs for mice", Vet Parasitol, 51, pp.283~288 (1994)